Literature DB >> 15318345

Beta-synemin localizes to regions of high stress in human skeletal myofibers.

Yuji Mizuno1, Jeffrey R Guyon, Simon C Watkins, Kazuyuki Mizushima, Toshikuni Sasaoka, Michihiro Imamura, Louis M Kunkel, Koichi Okamoto.   

Abstract

Synemin is an intermediate filament protein shown previously to interact with alpha-dystrobrevin and desmin. Immunoblot analysis detects a beta-synemin protein of 170 kDa in human skeletal muscle and an alpha-synemin protein of 225 kDa in monkey brain. Low-resolution immunohistochemical analysis localizes beta-synemin within muscle along the sarcolemma, whereas confocal microscopic analysis further refines localization to the costamere and muscle Z-lines. In addition to these locations, beta-synemin is also enriched at the neuromuscular and myotendinous junctions, other regions that undergo high stress during myofiber contraction. Based on its localization and its expression pattern, it is proposed that beta-synemin functions as a structural protein involved in maintaining muscle integrity through its interactions with alpha-dystrobrevin, desmin, and other structural proteins. Copyright 2004 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15318345     DOI: 10.1002/mus.20111

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  10 in total

1.  Synemin isoforms differentially organize cell junctions and desmin filaments in neonatal cardiomyocytes.

Authors:  Linda M Lund; Jaclyn P Kerr; Jenna Lupinetti; Yinghua Zhang; Mary A Russell; Robert J Bloch; Meredith Bond
Journal:  FASEB J       Date:  2011-10-07       Impact factor: 5.191

2.  Specific interaction of the actin-binding domain of dystrophin with intermediate filaments containing keratin 19.

Authors:  Michele R Stone; Andrea O'Neill; Dawn Catino; Robert J Bloch
Journal:  Mol Biol Cell       Date:  2005-07-06       Impact factor: 4.138

3.  Biomechanical Properties of the Sarcolemma and Costameres of Skeletal Muscle Lacking Desmin.

Authors:  Karla P Garcia-Pelagio; Robert J Bloch
Journal:  Front Physiol       Date:  2021-08-19       Impact factor: 4.755

4.  Immunohistochemical detection of dysbindin at the astroglial endfeet around the capillaries of mouse brain.

Authors:  Shoji Iijima; Hisatsugu Masaki; Yoshihiro Wakayama; Masahiko Inoue; Takahiro Jimi; Hajime Hara; Akihiko Unaki; Hiroaki Oniki; Kiyoko Nakano; Yoshiko Hirayama; Koji Kishimoto
Journal:  J Mol Histol       Date:  2009-06-04       Impact factor: 2.611

Review 5.  The role of α-dystrobrevin in striated muscle.

Authors:  Masayuki Nakamori; Masanori P Takahashi
Journal:  Int J Mol Sci       Date:  2011-03-04       Impact factor: 5.923

6.  The In Vitro Cytotoxic Effects of Ionophore Exposure on Selected Cytoskeletal Proteins of C2C12 Myoblasts.

Authors:  Danielle Henn; Annette Venter; Gezina C H Ferreira; Christo J Botha
Journal:  Toxins (Basel)       Date:  2022-06-30       Impact factor: 5.075

7.  Expression of synemin in the mouse spinal cord.

Authors:  Yuji Mizuno; Jeffrey R Guyon; Koichi Okamoto; Louis M Kunkel
Journal:  Muscle Nerve       Date:  2009-05       Impact factor: 3.217

8.  Absence of keratin 19 in mice causes skeletal myopathy with mitochondrial and sarcolemmal reorganization.

Authors:  Michele R Stone; Andrea O'Neill; Richard M Lovering; John Strong; Wendy G Resneck; Patrick W Reed; Diana M Toivola; Jeanine A Ursitti; M Bishr Omary; Robert J Bloch
Journal:  J Cell Sci       Date:  2007-10-30       Impact factor: 5.235

9.  Beta-synemin expression in cardiotoxin-injected rat skeletal muscle.

Authors:  Yuji Mizuno; Jeffrey R Guyon; Akiko Ishii; Sachiko Hoshino; Norio Ohkoshi; Akira Tamaoka; Koichi Okamoto; Louis M Kunkel
Journal:  BMC Musculoskelet Disord       Date:  2007-05-10       Impact factor: 2.362

10.  Analysis of skeletal muscle function in the C57BL6/SV129 syncoilin knockout mouse.

Authors:  Karl J A McCullagh; Ben Edwards; Matthew W Kemp; Laura C Giles; Matthew Burgess; Kay E Davies
Journal:  Mamm Genome       Date:  2008-07-02       Impact factor: 2.957

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.